Oxaliplatin and Topotecan in Advance Ovarian Cancer
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving oxaliplatin together with topotecan works in
treating patients with ovarian epithelial cancer, primary peritoneal cancer, or fallopian
tube cancer. Drugs used in chemotherapy, such as oxaliplatin and topotecan, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.